Clindamycin Hydrochloride and Sodium Chloride Injection

1. For the treatment of the following infectious diseases caused by Gram-positive bacteria: (1) tonsillitis, suppurative otitis media, sinusitis, etc.; (2) acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc.; (3) skin and soft tissue infections: furuncle, carbuncle, abscess, fossa inflammation, trauma and postoperative infection, etc.; (4) urinary tract infections: acute urethritis, acute pyelonephritis, prostatitis, etc.; (5) others: osteomyelitis, sepsis, peritonitis and oral infection, etc.; 2. For the treatment of various infectious diseases caused by anaerobic bacteria: (1) empyema, lung abscess, anaerobic lung disease; (2) skin and soft tissue infections, sepsis; (3) intra-abdominal infections: peritonitis, intra-abdominal abscess; (4) female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess, pelvic fossa inflammation and post-gynecological surgery infection, etc.

Patients with a history of allergy to clindamycin or lincomycin are contraindicated.

100ml: 0.3g clindamycin hydrochloride (calculated as clindamycin) and 0.9g sodium chloride

Wuhan Binhu Shuanghe Pharmaceutical Co., Ltd.

• Founded in:

  1999-05-06

• Address:

  Zuoling Industrial Park, East Lake New Technology Development Zone, Wuhan City, Hubei Province

• Tax NO.:

  914201001777229307

• Registered Funds:

  184.7082 million yuan

• Website:

  Log in to view

• Email:

  Log in to view